Skip to main content
PMC home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1999 Mar;83(3):339–342. doi: 10.1136/bjo.83.3.339

AIDS related eye disease in Burundi, Africa

I Cochereau 1, N Mlika-Cabanne 1, P Godinaud 1, T Niyongabo 1, B Poste 1, A Ngayiragije 1, M Dazza 1, P Aubry 1, B Larouze 1
PMCID: PMC1722983  PMID: 10365044

Abstract

AIMS—To determine the prevalence of ocular manifestations in AIDS patients hospitalised in Bujumbura, Burundi, according to their CD4+ lymphocyte count, serological status for CMV and VZV, and general health status.
METHODS—Prospective study of 154 consecutive patients who underwent general and ophthalmological examinations, including dilated fundus examination. AIDS was diagnosed on the basis of Bangui criteria and HIV-1 seropositivity. CD4+ lymphocyte counts were determined by the Capcellia method. CMV and VZV antibodies were detected with ELISA methods.
RESULTS—The mean age was 37 (SD 9) years and 65% of the patients were male. Active tuberculosis was the most frequent underlying disease (61%). Almost all the patients (99%) were seropositive for CMV and VZV. Among the 115 patients for whom CD4+ lymphocyte counts were available, 86 (75%) had more than 100 cells ×106/l. Ocular involvement comprised 16 cases of microangiopathy, six of opalescence of the anterior chamber, five of retinal perivasculitis, two of zoster ophthalmicus, two of viral retinitis, and one of opalescence of the vitreous.
CONCLUSION—In Africa, the prevalence of ocular involvement in HIV infection is far lower than in Europe and the United States, possibly because most African patients die before ocular opportunistic infections occur.

 Keywords: AIDS; eyes; Africa; CD4+ lymphocyte count

Full Text

The Full Text of this article is available as a PDF (89.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ateenyi-Agaba C. Conjunctival squamous-cell carcinoma associated with HIV infection in Kampala, Uganda. Lancet. 1995 Mar 18;345(8951):695–696. doi: 10.1016/s0140-6736(95)90870-6. [DOI] [PubMed] [Google Scholar]
  2. Auzemery A., Queguiner P., Georges A. J., Di Costanzo B., Georges-Courbot M. C., Vohito M. D. Manifestations ophtalmologiques du syndrome d'immunodépression acquise (SIDA) en Afrique centrale. Med Trop (Mars) 1990 Oct-Dec;50(4):441–443. [PubMed] [Google Scholar]
  3. Bello C., Whittle H. Cytomegalovirus infection in Gambian mothers and their babies. J Clin Pathol. 1991 May;44(5):366–369. doi: 10.1136/jcp.44.5.366. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Carriere D., Fontaine C., Berthier A. M., Rouquette A. M., Carayon P., Laprode M., Juillard R., Jansen A., Paoli P., Paolucci F. Two-site enzyme immunoassay of CD4 and CD8 molecules on the surface of T lymphocytes from healthy subjects and HIV-1-infected patients. Clin Chem. 1994 Jan;40(1):30–37. [PubMed] [Google Scholar]
  5. De Cock K. M., Soro B., Coulibaly I. M., Lucas S. B. Tuberculosis and HIV infection in sub-Saharan Africa. JAMA. 1992 Sep 23;268(12):1581–1587. doi: 10.1001/jama.268.12.1581. [DOI] [PubMed] [Google Scholar]
  6. Fekrat S., Dunn J. P., Lee D., Miller T., Jabs D. A. Cytomegalovirus retinitis in HIV-infected patients with elevated CD4+ counts. Arch Ophthalmol. 1995 Jan;113(1):18–18. doi: 10.1001/archopht.1995.01100010020007. [DOI] [PubMed] [Google Scholar]
  7. Freeman W. R., Chen A., Henderly D. E., Levine A. M., Luttrull J. K., Urrea P. T., Arthur J., Rasheed S., Cohen J. L., Neuberg D. Prevalence and significance of acquired immunodeficiency syndrome-related retinal microvasculopathy. Am J Ophthalmol. 1989 Mar 15;107(3):229–235. doi: 10.1016/0002-9394(89)90304-8. [DOI] [PubMed] [Google Scholar]
  8. Gilks C. F. The clinical challenge of the HIV epidemic in the developing world. Lancet. 1993 Oct 23;342(8878):1037–1039. doi: 10.1016/0140-6736(93)92885-w. [DOI] [PubMed] [Google Scholar]
  9. Holland G. N., Pepose J. S., Pettit T. H., Gottlieb M. S., Yee R. D., Foos R. Y. Acquired immune deficiency syndrome. Ocular manifestations. Ophthalmology. 1983 Aug;90(8):859–873. doi: 10.1016/s0161-6420(83)80009-8. [DOI] [PubMed] [Google Scholar]
  10. Jabs D. A., Green W. R., Fox R., Polk B. F., Bartlett J. G. Ocular manifestations of acquired immune deficiency syndrome. Ophthalmology. 1989 Jul;96(7):1092–1099. doi: 10.1016/s0161-6420(89)32794-1. [DOI] [PubMed] [Google Scholar]
  11. Kamanfu G., Mlika-Cabanne N., Girard P. M., Nimubona S., Mpfizi B., Cishako A., Roux P., Coulaud J. P., Larouzé B., Aubry P. Pulmonary complications of human immunodeficiency virus infection in Bujumbura, Burundi. Am Rev Respir Dis. 1993 Mar;147(3):658–663. doi: 10.1164/ajrccm/147.3.658. [DOI] [PubMed] [Google Scholar]
  12. Kawe L. W., Renard G., Le Hoang P., Kayembe L., Odio W. Manifestations ophtalmologiques du SIDA en milieu africain. A propos de 45 cas. J Fr Ophtalmol. 1990;13(4):199–204. [PubMed] [Google Scholar]
  13. Kestelyn P., Lepage P., Van de Perre P. Perivasculitis of the retinal vessels as an important sign in children with AIDS-related complex. Am J Ophthalmol. 1985 Oct 15;100(4):614–615. doi: 10.1016/0002-9394(85)90693-2. [DOI] [PubMed] [Google Scholar]
  14. Kestelyn P., Stevens A. M., Bakkers E., Rouvroy D., Van de Perre P. Severe herpes zoster ophthalmicus in young African adults: a marker for HTLV-III seropositivity. Br J Ophthalmol. 1987 Nov;71(11):806–809. doi: 10.1136/bjo.71.11.806. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kestelyn P., Taelman H., Bogaerts J., Kagame A., Abdel Aziz M., Batungwanayo J., Stevens A. M., Van de Perre P. Ophthalmic manifestations of infections with Cryptococcus neoformans in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol. 1993 Dec 15;116(6):721–727. doi: 10.1016/s0002-9394(14)73472-5. [DOI] [PubMed] [Google Scholar]
  16. Kestelyn P., Van de Perre P., Rouvroy D., Lepage P., Bogaerts J., Nzaramba D., Clumeck N. A prospective study of the ophthalmologic findings in the acquired immune deficiency syndrome in Africa. Am J Ophthalmol. 1985 Aug 15;100(2):230–238. doi: 10.1016/0002-9394(85)90787-1. [DOI] [PubMed] [Google Scholar]
  17. Kuppermann B. D., Petty J. G., Richman D. D., Mathews W. C., Fullerton S. C., Rickman L. S., Freeman W. R. Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol. 1993 May 15;115(5):575–582. doi: 10.1016/s0002-9394(14)71453-9. [DOI] [PubMed] [Google Scholar]
  18. Lewallen S., Kumwenda J., Maher D., Harries A. D. Retinal findings in Malawian patients with AIDS. Br J Ophthalmol. 1994 Oct;78(10):757–759. doi: 10.1136/bjo.78.10.757. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lucas S. B., Hounnou A., Peacock C., Beaumel A., Djomand G., N'Gbichi J. M., Yeboue K., Hondé M., Diomande M., Giordano C. The mortality and pathology of HIV infection in a west African city. AIDS. 1993 Dec;7(12):1569–1579. doi: 10.1097/00002030-199312000-00005. [DOI] [PubMed] [Google Scholar]
  20. Mukadi Y., Perriëns J. H., St Louis M. E., Brown C., Prignot J., Willame J. C., Pouthier F., Kaboto M., Ryder R. W., Portaels F. Spectrum of immunodeficiency in HIV-1-infected patients with pulmonary tuberculosis in Zaire. Lancet. 1993 Jul 17;342(8864):143–146. doi: 10.1016/0140-6736(93)91346-n. [DOI] [PubMed] [Google Scholar]
  21. Olaleye O. D., Omilabu S. A., Baba S. S. Cytomegalovirus infection among tuberculosis patients in a chest hospital in Nigeria. Comp Immunol Microbiol Infect Dis. 1990;13(2):101–106. doi: 10.1016/0147-9571(90)90522-u. [DOI] [PubMed] [Google Scholar]
  22. Palestine A. G., Rodrigues M. M., Macher A. M., Chan C. C., Lane H. C., Fauci A. S., Masur H., Longo D., Reichert C. M., Steis R. Ophthalmic involvement in acquired immunodeficiency syndrome. Ophthalmology. 1984 Sep;91(9):1092–1099. doi: 10.1016/s0161-6420(84)34201-4. [DOI] [PubMed] [Google Scholar]
  23. Pepose J. S., Holland G. N., Nestor M. S., Cochran A. J., Foos R. Y. Acquired immune deficiency syndrome. Pathogenic mechanisms of ocular disease. Ophthalmology. 1985 Apr;92(4):472–484. doi: 10.1016/s0161-6420(85)34008-3. [DOI] [PubMed] [Google Scholar]
  24. Pertel P., Hirschtick R., Phair J., Chmiel J., Poggensee L., Murphy R. Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus. J Acquir Immune Defic Syndr. 1992;5(11):1069–1074. [PubMed] [Google Scholar]
  25. Quinn T. C., Piot P., McCormick J. B., Feinsod F. M., Taelman H., Kapita B., Stevens W., Fauci A. S. Serologic and immunologic studies in patients with AIDS in North America and Africa. The potential role of infectious agents as cofactors in human immunodeficiency virus infection. JAMA. 1987 May 15;257(19):2617–2621. [PubMed] [Google Scholar]
  26. Tudor-Williams G. Early diagnosis of vertically acquired HIV-1 infection. AIDS. 1991 Jan;5(1):103–105. doi: 10.1097/00002030-199101000-00017. [DOI] [PubMed] [Google Scholar]
  27. Whittle H., Egboga A., Todd J., Corrah T., Wilkins A., Demba E., Morgan G., Rolfe M., Berry N., Tedder R. Clinical and laboratory predictors of survival in Gambian patients with symptomatic HIV-1 or HIV-2 infection. AIDS. 1992 Jul;6(7):685–689. doi: 10.1097/00002030-199207000-00011. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES